Biotechnology - Asia-Pacific

Filter

Current filters:

Asia-Pacific

Popular Filters

151 to 166 of 166 results

Panacea Biotech inaugurates new cancer drug facility in India

28-03-2012

Indian health care management company Panacea Biotec says that it has inaugurated a new state-of-the-art…

Asia-PacificBiotechnologyFinancialMarkets & MarketingPanacea Biotec

Pharming in deal with Hyupjin for Ruconest in South Korea

27-03-2012

Dutch biotech firm Pharming Group (NYSE Euronext: PHARM) has entered into an agreement with Seoul-based…

Asia-PacificBiotechnologyHyupjin CorpLicensingPharmingRare diseasesRhucinRuconest

Anaphore buys Chinese firm RuiYi for GPCR biologics platform

23-03-2012

Privately-held US company Anaphore says it has acquired Shanghai, China-based RuiYi, bringing the company…

AnaphoreAsia-PacificBiotechnologyMergers & AcquisitionsRuiYi

New IP legislation will encourage medical research in Australia, says trade group

20-03-2012

New legislation overhauling the Australian patent system will encourage medical research and bring Australia…

Asia-PacificBiotechnologyLegalPatentsPharmaceuticalResearch

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Apexigen licenses MAb to Gansu Duyiwei for China

12-03-2012

Privately-held US biopharma firm Apexigen has entered into a collaboration to grant an exclusive license…

ApexigenAsia-PacificBiotechnologyGansu DuyiweiLicensingOncology

AusBiotech sets out stall on R&D tax incentive discussion paper

07-02-2012

Australian trade group AusBiotech has lodged a submission in response to the “Discussion Paper:…

Asia-PacificBiotechnologyFinancialResearch

Immuron joins academia for C. Difficile therapeutics

31-01-2012

Australian biotechnology firm Immuron (ASX: IMC) has entered into a collaboration agreement with Australia’s…

Antibiotics and Infectious diseasesAsia-PacificBiotechnologyImmuronResearch

Overview of biologic regulations in India

26-01-2012

Currently, all biologics in India, including innovative and copy biologics are approved as new drugs,…

Asia-PacificBiotechnologyGenericsRegulation

A new year and good news is rolling in already, says AusBiotech

25-01-2012

Last year ended on a high for Australian biotechnology industry policy - with the R&D Tax Incentive up…

Asia-PacificBiotechnologyFinancialLicensing

Japanese approval for Regnite and Ranmark

18-01-2012

Japanese drug major Astellas Pharma (TYO: 4503) and USA-based XenoPort (Nasdaq: XNPT) revealed yesterday…

AmgenAsia-PacificAstellas PharmaAstraZenecaBiotechnologyDaiichi SankyodenosumabFinancialNeurologicalOncologyPharmaceuticalRanmarkRegniteRegulationXenoPort

Investment in medicines highest in PHARMAC history

15-12-2011

A surge in the medicines budget over the past three years, combined with New Zealand’s health regulatory…

Asia-PacificBiotechnologyFinancialPharmaceuticalPricingRegulation

Cuba and China sign deals to boost biotechnology cooperation

28-11-2011

Cuba and China have reached agreement to strengthen cooperation on biotechnology, said Cuban Science…

Asia-PacificBiotechnologyPoliticsResearchSouth America

SK biopharma in licensing deal with China’s Medicilon for depression/bipolar drug candidate

02-11-2011

South Korean biotech firm SK biopharmaceuticals says it has entered into an R&D agreement with Medicilon,…

Asia-PacificBiotechnologyLicensingMedicilonNeurologicalPharmaceuticalSK biopharmaceuticals

151 to 166 of 166 results

Parexel

Parexel

Back to top